Pharmacological Studies
HPR specializes in efficacy testing of therapeutics in cynomolgus macaque disease models.
We also provide pharmacological consultation for your research and development programs.
HPR's Primate Center and Central Research Facility are located in Hamamatsu, Japan.

Central Nervous System
-
Stroke
-
Photochemically-induced thrombosis (PIT)
-
Thromboembolic
-
Transient and permanent occlusion
-
-
Neurological disease
-
Parkinson's disease
-

Pain
-
Capsaicin-induced acute pain
-
Oxaliplatin-induced polyneuropathic pain
-
Postoperative pain
-
Visceral pain
-
Peripheral monneuropathic pain
-
Osteoarthritis (OA)

Ophthalmology
-
Age-related macular degeneration
-
dry AMD and wet AMD
-
-
Glaucoma

Gastroenterology
-
Inflammatory bowel disease (IBD)
-
Visceral pain/Irritable bowel syndrome (IBS)

Other Therapeutic Areas
-
Cardiovascular disorders
-
Thrombosis
-
-
Reproductive diseases
-
Naturally-occuring endometriosis
-
-
Skin disorders
-
Pruritus
-
HPR Therapeutic Studies
Our services
When it comes to designing a preclinical pharmacological study, a well thought out process-flow, appropriate selection of an animal model and well defined experimental endpoints are critical.
With HPR’s expertise in preclinical pharmacology, your study will be fully supported every step of the way.



Study Consultation
-
Study protocol design utilizing a NHP disease model
-
Study planning and execution
Disease Model Customization
-
Customization of existing models
-
New model development
Pharmacological Studies
-
Primary therapeutic areas:
Pain, Stroke, Endometriosis, OA, AMD, Glaucoma, IBD, Thrombosis, and Pruritus -
Other therapeutic areas available on request

NHP Biological Materials
NHP material for in vitro translational research
(limited availability, please inquire)
-
Control tissues
-
Disease tissues
-
Tissues for pharmacokinetic testing

NHP Housing
Short- and long-term housing of cynomolgus macaques
Please contact us for more details concerning our NHP models and services